Drug supply answer supplier on Wednesday mentioned it’s planning to get listed on the Nationwide Inventory Change of India (NSE) on November 25. ZIM Laboratories, already listed on the BSE since June 2018, will now lengthen its itemizing to the NSE, the corporate mentioned in a press release.
As of date, the corporate mentioned, it has supplied over 85 per cent return to its traders from the itemizing worth.
In keeping with the September 2022 shareholding sample obtainable with the BSE, the corporate’s promoters personal a 33.26 per cent stake within the agency, of which, Dr Anwar Daud, Chairman and Managing Director, holds a 27.37 per cent stake and Mathew Cyriac, Government Chairman, Florintree Advisors, as an investor owns 21.86 per cent.
ZIM Laboratories is a pharmaceutical firm, targeted on offering revolutionary drug supply options that present affected person comfort and adherence to drug remedy.
